International Market Access Consulting (IMAC), consists of a global team of passionate individuals with decades of industry and consulting experience. Our team provides custom, high-impact, market access strategies and specialized, evidence‑based tools to effectively communicate the value of your product to key stakeholders in the payer landscape. As a specialist market access consulting company with a proven track record of success, we possess a high level of technical and scientific expertise to help our clients achieve their goals of optimized patient access for their products.
Eva Tsakonas
Eva has 30 years of research experience in academia, government, and the pharmaceutical industry and has been a consultant since 2006. Over this time period she has worked on over 200 projects that have included the conduct and analysis of clinical studies, registries, and population-based datasets, national economic burden of illness studies, economic evaluations and BIAs for HTA agencies such as CADTH as well as for the pharmaceutical industry, and on systematic reviews for HTA agencies and for submissions to CADTH, NICE, IQWIG, and others. She has been economic reviewer for pCODR and has reviewed submissions for new diagnostic tests for INESSS. She has worked in numerous disease areas including infectious diseases, cardiology, trauma, cancer, rheumatology, dermatology, genetic disorders and genetic testing, obesity, respiratory illnesses, mental health, and rare disorders. Eva brings experience and a commitment to producing high quality research to all her projects.